Efficacy of the induced pluripotent stem cell derived and engineered CD276-targeted CAR-NK cells against human esophageal squamous cell carcinoma.

Front Immunol · 2024 · PMC10985341 · PMID 38566988

Europe PMC DOI

hedged sentence

0.1941

closest p · 3.9× alpha

0.1941

boldest claim

The sentences

did not reach statistical significanceP=0.1941not close (p > 0.1)

However, the difference in tumor growth between the iPSC CD276-targeted CAR-NK group and the iPSC NK cell group did not reach statistical significance (P=0.1941) when considering the overall comparison of the two curves throughout the entire 25-day observation period ( Figure 5A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.